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Postoperative cognitive dysfunction (POCD), mainly characterized by short-term decline
of learning and memory, occurs after operations under anesthesia. However, the
underlying mechanisms are poorly understood. The µ-opioid receptors (MOR) are
highly expressed in interneurons of hippocampus, and is believed to be critical for
the dysfunction of synaptic plasticity between hippocampal neurons. Therefore, we
investigated the effect of fentanyl, a strong agonist of MOR and often used for anesthesia
and analgesia in clinical settings, on hippocampal synaptic plasticity in the Schaffer-
collateral CA1 pathway during acute exposure and washout in vitro. Our results revealed
that acute fentanyl exposure (0.01, 0.1, 1µM) dose-dependently increased the field
excitatory postsynaptic potentials (fEPSPs), which was prevented by pre-administration
of picrotoxin (50µM) or MOR antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Phe-Thr-NH2
(CTOP, 10µM). While fentanyl exposure-increased fEPSPs amplitude was prevented by
picrotoxin [an inhibitor of γ-aminobutyric acid receptor (GABAR)] treatment or fentanyl
washout, pretreatment of picrotoxin failed to prevent the fentanyl-impaired long-term
potentiation (LTP) of synaptic strength as well as the fentanyl-enhanced long-term
depression (LTD). These results demonstrated that fentanyl acute exposure and washout
increases hippocampal excitability in the Schaffer-collateral CA1 pathway, depending
on disinhibiting interneurons after MOR activation. In addition, fentanyl acute exposure
and washout modulated synaptic plasticity, but the inhibitory activation was not critical.
Elucidating the detailed mechanisms for synaptic dysfunction after fentanyl exposure and
washout may provide insights into POCD generation after fentanyl anesthesia.
Keywords: fentanyl, hippocampus, LTP, fEPSP, µ-opioid receptor, interneuron
INTRODUCTION
Naturally produced and synthesized opioid receptor agonists are often used as anesthetics and
analgesics in clinical settings. Some patients who received regional or general anesthesia for
surgery experience a short-term decline after surgery in cognitive function such as learning and
memory; this is known as postoperative cognitive disorder (POCD; Moller et al., 1998; Rasmussen,
2006; Newman et al., 2007). Increasing evidence suggests that aging, duration of anesthesia, and
postoperative infections rather than cerebral hypoxia are associated with POCD (Moller et al., 1998;
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Rasmussen, 2006; Newfield, 2009; Stenvall et al., 2012). However,
themechanisms that underlie POCDdevelopment remain largely
unknown.
The hippocampus is a brain structure critical for learning
and memory. Long-term potentiation (LTP) and long-term
depression (LTD) of synaptic strength at the glutamatergic
synapses in the hippocampus are well-characterized forms
of synaptic plasticity and have long been believed to be
a cellular mechanism underlying learning and memory
(Bliss and Collingridge, 1993; Malenka and Nicoll, 1999).
In rats, electrophysiological, immunohistochemical, and in
situ hybridization experiments have demonstrated that the
hippocampus expresses a high density of opioid receptors
(Zieglgänsberger et al., 1979; Lupica et al., 1992; Drake and
Milner, 2002; Stumm et al., 2004; Drake et al., 2007). Along
with these studies, µ-opioid receptors (MOR) are selectively
expressed on GABAergic interneurons within the CA1 region
of the hippocampus (Drake and Milner, 1999; Stumm et al.,
2004). Because of this interneuron expression profile of
MOR, acute activation of MOR in the hippocampal CA1 area
increases glutamatergic excitatory neuronal transmission by
hyperpolarizing interneurons and inhibiting GABA release
(Capogna et al., 1993; Svoboda and Lupica, 1998). Therefore, the
enhanced excitatory neuronal transmission in the hippocampal
CA1 region after opioid exposure is considered a secondary
effect due to its disinhibiting effect. While activation of opioid
receptors in the hippocampus by acute and chronic opioid
exposure have demonstrated modulation of hippocampal
plasticity and memory (Yang et al., 2004; Jafari-Sabet and Jannat-
Dastjerdi, 2009), the role of acute MOR activation and washout
in hippocampal synaptic plasticity of the Schaffer-collateral CA1
pathway remains elusive.
Fentanyl, an agonist of MOR largely used in human
patients for anesthesia and analgesia associated with surgery,
has been demonstrated to decrease GABA-mediated synaptic
transmission from interneurons of the CA1 region 24 h
after a single dose in vivo treatment (Kouvaras et al.,
2008), which led to an increased susceptibility of pyramidal
neurons to presynaptic stimulation. In in vitro cultured
hippocampal neurons, synaptic α-amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid glutamate receptors (AMPAR) and
dendritic spins were reported to be changed within 24 h
of fentanyl exposure (Lin et al., 2009). In the peripheral
C-fiber synapses, acute fentanyl exposure decreased presynaptic
neurotransmission, but persistently potentiated neurotransmitter
release from presynaptic sites when withdrawn from the acute
treatment (Heinl et al., 2011). However, whether fentanyl
acute exposure and washout directly affects glutamatergic
synaptic function in the Schaffer-collateral CA1 pathway remains
unknown.
In the present study, we exposed hippocampal slices to
fentanyl and recorded its effects on glutamatergic synaptic
transmission and plasticity in the presence or blockade of
GABAergic inhibition. We aimed to see if fentanyl, similar to
morphine, can modulate glutamatergic synaptic plasticity in the
Schaffer-collateral pathway, and particularly to examine whether
inhibitory neurotransmission is involved.
MATERIALS AND METHODS
Animals
This study was approved by the Animal Care and Use
Committee of No. 324 Hospital of the People’s Liberation Army
in accordance with the International Guiding Principles for
Animals Research as stipulated by the Council for International
Organizations of Medical Sciences (1985). Sprague Dawley (SD)
male adults (8–10 weeks) were group-housed, with ad libitum
access to water and food in the established animal houses, a
12 h light/dark cycle and a thermoregulated environment. All
efforts were made to minimize the number of rats used and their
suffering.
Electrophysiological Studies
Electrophysiological recordings were performed on coronal
hippocampal slices (400µm in thickness), as described
previously (Wang and Belousov, 2011). Hippocampal slices were
recovered at 37◦C for at least 1 h and then maintained in an
interface chamber at 29◦C and perfused with ACSF (124mM
NaCl, 4.4mM KCl, 1mM Na2HPO4, 25mM NaHCO3, 2mM
CaCl2, 2mMMgSO4, and 10mM glucose) continuously bubbled
with 95% O2 and 5% CO2. fEPSPs were recorded from the CA1
region of the hippocampus by placing both the stimulating and
the recording electrodes in the CA1 stratum radiatum. Basal
synaptic transmission was assayed by plotting the stimulus
voltage (V) against amplitudes of fEPSP to generate input-
output relations. A baseline recording was established using
low-frequency stimulation (0.033Hz; 0.1ms impulse duration)
with adjusted intensity that induced fEPSPs with ∼40% of the
maximal fEPSP amplitude. LTP was induced using theta-burst
stimulation (10 epochs was delivered at 5Hz and each epoch
consists 4 pulses at 100Hz). LTD was induced using 3Hz of 900
pulses stimulation. In experiments using inhibitors, drugs were
continuously perfused over slices starting at least 10min before
fentanyl exposure, unless otherwise stated. Values of fEPSP
amplitude were expressed as mean ± SEM percentage change
relative to their mean baseline amplitude.
Drug Treatments
Drugs were prepared as stock solutions and diluted to the final
concentration immediately before use. Final concentrations and
sources of the drugs were as follows: fentanyl citrate salt (0.01, 0.1,
1µM; Sigma), picrotoxin (50µM; Sigma), and D-Phe-Cys-Tyr-
D-Trp-Orn-Thr-Phe-Thr-NH2 (CTOP, 10µM; Sigma). Saline or
dimethyl sulfoxide (DMSO) was used as vehicle control and the
final concentration of DMSO control was less than 0.5% in all
experiments. Incubation of hippocampal slices with drugs was
performed in either a recovery chamber or interface-recording
chamber as needed.
Statistical Analysis
All data are presented as mean ± standard error of the
mean (SEM). One-way ANOVA followed by Fisher’s post-hoc
comparisons was used for analyzing the difference between
groups, using Stat View 5.0.1 software (SAS Institute, Cary NC).
P < 0.05 was considered significant.
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in the CA1 Region in a MOR- and
GABAR-Dependent Manner
Given that acute in vivo fentanyl injection decreased
GABA-mediated neurotransmission from hippocampal CA1
interneurons 24 h after treatment (Kouvaras et al., 2008), we
first examined if acute exposure of fentanyl to hippocampal
slices increased fEPSPs amplitude in the Schaffer-collateral
pathway where both presynaptic glutamate and GABA releases
were integrated. As shown in Figure 1A, in the absence of
GABAergic neurotransmission, lower concentration of fentanyl
acute exposure did not significantly alter synaptic transmission
(Figures 1A,D; p > 0.05 Fen-0.01 group vs. Vehicle group),
but the higher concentration of fentanyl treatment significantly
potentiated fEPSPs amplitudes (Figures 1A,D; p < 0.01 Fen-1
group vs. Vehicle group). In contrast to its role in inducing
“withdrawal LTP” in C-fiber synapses (Heinl et al., 2011),
the fEPSPs of Schaffer-collateral synapses were not further
potentiated by fentanyl washout immediately following the
acute fentanyl exposure (Figure 1A). Indeed, fentanyl-increased
fEPSPs amplitude was declined to baseline levels by a 60min
drug washout (Figure 1A). Next, we evaluated the effect
of fentanyl exposure and washout on excitatory synaptic
transmission in the CA1 region when the GABA-mediated
inhibition by interneurons was prevented. When fentanyl
(1µM) was exposed to picrotoxin (50µM) pre-treated slices
(for at least 30min pre-incubation), there was no significant
further facilitation of fEPSPs amplitude in the Schaffer-
collateral pathway (Figures 1B,D; p > 0.05 Pic/Fen-1 group
vs. Pic/Vehicle group), and fentanyl washout did not change
fEPSPs either. These results suggested that fentanyl exposure
indirectly promoted excitatory neurotransmission in the CA1
via inhibiting interneuron GABAergic input.
To investigate the role of MOR activation in the fentanyl-
mediated increase of fEPSPs amplitude, we pretreated with
CTOP (10µM, a selective antagonist of MOR), 10min before
FIGURE 1 | Effect of fentanyl on basic synaptic transmission in the hippocampal CA1 area. (A) The amplitude of fEPSPs was increased by fentanyl exposure
(30min, solid horizontal bar) in a dose-dependent manner. However, the elevated fEPSPs response was completely restored after a 60min washout. Fen-0.01:
0.01µM fentanyl; Fen-0.1: 0.1µM fentanyl; Fen-1: 1µM fentanyl. (B) In the slices with pretreatment of 50µM picrotoxin (Pic, open bar, for at least 30min), fentanyl
exposure and washout did not change basic synaptic transmission. (C) In the presence of 10µM CTOP (open bar), fentanyl exposure and washout did not change
basic synaptic transmission. (D) Basic synaptic transmission among the indicated groups was calculated by an average of fEPSP amplitudes during baseline
(0–10min) and the last 10min of fentanyl exposure (30–40min). *p < 0.05, **p < 0.01 baseline vs. 30–40min. Data presented as mean ± SEM. N = 8–12 per group
from five rats.
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fentanyl exposure and washout. As we show in Figure 1C,
no significant alteration in amplitude of the fEPSPs was
detected (Figures 1C,D; p > 0.05 CTOP/Fen-1 group vs.
CTOP/Vehicle group). This result indicated that activation
of MOR is required for fentanyl-induced basic synaptic
transmission changes.
Fentanyl Acute Exposure and Washout
Impaired LTP but Facilitated LTD in the
CA1 Region in a Inhibitory
Neurotransmission-independent Manner
Since hippocampal plasticity is considered a cellular mechanism
for learning and memory (Bliss and Collingridge, 1993; Malenka
and Nicoll, 1999), we then evaluated the effect of fentanyl acute
exposure and washout on hippocampal plasticity in the CA1
region under an in vitro condition. We delivered stimulations to
induce LTP and LTD 1.5 h after fentanyl washout that followed
a 30min acute exposure period. The results revealed that the
LTP induction was impaired by fentanyl exposure and washout
(Figures 2A,C; p < 0.05 Fen-1 group vs. Vehicle group), with
facilitation in LTD expression (Figures 2B,C; p < 0.05 Fen-1
group vs. Vehicle group).
Given that interneurons mediated the effect of fentanyl on
basic synaptic transmission (Figure 1), we next investigated if
inhibitory neurotransmission was required for the modulation
of fentanyl on synaptic plasticity. While LTP was slightly
increased from non-fentanyl-treated hippocampal slices in the
presence of picrotoxin (50µM), a reduced LTP was observed
after fentanyl exposure and washout (Figures 3A,C; p < 0.05
Pic/Fen-1 group vs. Pic/Vehicle group). Similarly, blockade
of inhibitory neurotransmission by picrotoxin treatment
did not prevent fentanyl-facilitated LTD in the CA1 area
(Figures 3B,C; p < 0.05 Pic/Fen-1 group vs. Pic/Vehicle
group).
To determine if MOR is involved in fentanyl-modulated
synaptic plasticity, the hippocampal slices were pretreated
with CTOP (10µM) 10min before fentanyl exposure and
the LTP and LTD inductions were recorded. We found that
inactivation of MOR by CTOP completely removed the effects
of fentanyl on both LTP (Figures 4A,C; p > 0.05 CTOP/Fen-
1 group vs. CTOP/Vehicle group) and LTD (Figures 4B,C;
p > 0.05 CTOP/Fen-1 group vs. CTOP/Vehicle group)
of synaptic plasticity. These results suggested that fentanyl-
modulated synaptic plasticity was the consequence of its action
on MOR.
DISCUSSION
Many opioids such as morphine modulate basic synaptic
transmission and plasticity in the hippocampal CA1 region,
via activating several types of opioid receptor (µ-, σ-, κ-opioid
receptors; Velísek et al., 2000; Yang et al., 2003, 2004; Dong
et al., 2007, 2010; Nugent and Kauer, 2008; Hosseinmardi et al.,
2009; Dacher and Nugent, 2011). In the present study, we report
here that selective activation of MOR by in vitro fentanyl acute
exposure and washout to hippocampal slices increased basic
synaptic transmission in the Schaffer-collateral pathway, through
its effect on disinhibition of GABAergic interneurons. More
interestingly, fentanyl treatment shifted long-term plasticity of
hippocampal synapses in favor of LTD induction, and the effect
of fentanyl on synaptic plasticity was different from its effect
on basic synaptic transmission, although both required MOR
activation.
In the central and peripheral nervous systems, acute exposure
to opioids activated G-protein coupled receptors, promoted
FIGURE 2 | Effect of fentanyl exposure and washout on LTP in the hippocampal CA1 area. (A) Hippocampal LTP was recorded after 30min fentanyl (1µM)
exposure and 60min washout in the indicated groups. LTP was reduced in fentanyl-treated slices. (B) Hippocampal LTD was recorded after 30min fentanyl (1µM)
exposure and 60min washout in the indicated groups. LTD was facilitated in fentanyl-treated slices. (C) LTP and LTD readings among indicated groups were
calculated by an average of fEPSP amplitudes during baseline (0–20min) and the last 10min of recordings (70–80min). *p < 0.05, **p < 0.01 Vehicle-treated group vs.
fentanyl-treated group. Data presented as mean ± SEM. N = 9–14 per group from six rats. Inserts show representative traces of fEPSP in slices treated with vehicle
(black) or 1µM fentanyl (red) before tetanus stimulation (solid line) and at the end of 1 h recording (dash line); scale bars represent 5ms and 0.5mV, respectively.
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FIGURE 3 | Effect of fentanyl exposure and washout on LTP in the hippocampal CA1 area in the presence of 50 µM picrotoxin (Pic, open bar, 10min
before fentanyl/vehicle treatment). (A) Hippocampal LTP was recorded after 30min fentanyl (1µM) exposure and 60min washout in the indicated groups. LTP
was reduced in fentanyl-treated slices. (B) Hippocampal LTD was recorded after 30min fentanyl (1µM) exposure and 60min washout in the indicated groups. LTD
was facilitated in fentanyl-treated slices. (C) LTP and LTD readings among indicated groups were calculated by an average of fEPSP amplitudes during baseline
(0–20min) and the last 10min of recordings (70–80min). *p < 0.05, **p < 0.01 Pic/Vehicle group vs. Pic/Fen-1 group. Data presented as mean ± SEM. N = 8–12 per
group from six rats. Inserts show representative traces of fEPSP in slices treated with picrotoxin/vehicle (black) or picrotoxin/1µM fentanyl (red) before tetanus
stimulation (solid line) and at the end of 1 h recording (dash line); scale bars represent 5ms and 0.5mV, respectively.
FIGURE 4 | Effect of fentanyl exposure and washout on LTP in the hippocampal CA1 area in the presence of 10 µM CTOP (open bar, 10min before
fentanyl/vehicle treatment). (A) Hippocampal LTP was recorded after 30min fentanyl (1µM) exposure and 60min washout in the indicated groups.
(B) Hippocampal LTD was recorded after 30min fentanyl (1µM) exposure and 60min washout in the indicated groups. (C) LTP and LTD among indicated groups
were calculated by an average of fEPSP amplitudes and comparisons were made between baseline (0–20min) and the last 10min of recordings (70–80min). NS,
non-significance CTOP/Vehicle vs. CTOP/Fen-1 group. Data presented as mean ± SEM. N = 8–10 per group from six rats. Inserts show representative traces of
fEPSP in slices treated with CTOP/vehicle (black) or CTOP/1µM fentanyl (red) before tetanus stimulation (solid line) and at the end of 1 h recording (dash line); scale
bars represent 5ms and 0.5mV, respectively.
potassium eﬄux, and inhibited calcium influx, which has
been shown to generally inhibit neurotransmitter release and
result in neuronal activity (Al-Hasani and Bruchas, 2011).
However, opioid receptors in the hippocampus are mainly
expressed in interneurons (Drake and Milner, 1999; Stumm
et al., 2004), and activation of opioid receptors in interneurons
reduces GABA release that normally carries inhibitory input
to pyramidal neurons. Therefore, in the hippocampus, opioid
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exposure leads to an increased glutamatergic excitatory neuronal
transmission by hyperpolarizing interneurons and GABA release
inhibition (Capogna et al., 1993; Svoboda and Lupica, 1998).
We should note that the effect of in vitro acute exposure of
hippocampal tissue to opioids on CA1 synaptic transmission
remains controversial. An earlier study demonstrated that acute
in vitro application of opioid receptor agonists enhanced synaptic
transmission in the CA1 area of the hippocampus (Dingledine,
1981); recently, MOR activation by opioids was also reported
to increase hippocampal network activity recorded in the CA1
region (Giannopoulos and Papatheodoropoulos, 2013). However,
it is also characterized by lack of effect on glutamatergic synaptic
transmission by acute in vitro exposure of organotypic rat
hippocampal slice cultures to MOR-preferring agonist D-Ala2,
MePhe4, Met(O)5-ol-enkephalin (FK 33-824) in the CA3 region
of the hippocampus (Capogna et al., 1993). In the present study,
our results indicated that acute fentanyl exposure to hippocampal
slices increased the amplitude of fEPSPs in Schaffer-collateral
CA1 synapses, and this effect was prevented by inactivation of
MOR or removal of GABA-mediated inhibition. Therefore, our
findings support that in vitro acute opioid exposure can lead
to an increase in CA1 basic synaptic transmission, which is
indirect from the disinhibition mediated by GABA-containing
interneurons. In addition, we observed that the fentanyl-
increased fEPSPs in vitro were decreased to baseline levels within
1 h after drug washout, which was also different from the in
vivo acute treatment in which the facilitation lasted for several
hours (Yang et al., 2004). This difference might derive from
the activation of MOR in other brain regions following in
vivo injection, rather than limited to hippocampus in in vitro
treatment.
While the in vitro acute effect of fentanyl on hippocampal
synaptic plasticity has not been fully investigated, it is known
that in vivo acute opioid administration facilitated hippocampal
LTD in the Schaffer-collateral CA1 pathway (Yang et al.,
2004). In addition, opioid exposure during the prenatal period
was reported to impair hippocampal LTP and facilitate LTD
induction in Schaffer-collateral synapses (Velísek et al., 2000;
Yang et al., 2003). Similar to acute in vivo administration, chronic
exposure to opioids has been shown to reduce LTP in the CA1
area of the hippocampus in both in vivo (Pu et al., 2002) and
in vitro experiments (Salmanzadeh et al., 2003). Our results in the
present study revealed that acute fentanyl exposure and washout
suppressed hippocampal LTP but facilitated LTD expression in
the Schaffer-collateral pathway.
The significant finding of the present study was that
activation of MOR by fentanyl might target distinct mechanisms
for modulating basic synaptic transmission and activity-
dependent synaptic plasticity. For the increase of basic
excitatory synaptic transmission, the fentanyl-induced MOR
activation in interneurons caused disinhibition of excitatory
synaptic connection and transmission, which has been well
described in the literature (Al-Hasani and Bruchas, 2011).
However, our findings of the effect of fentanyl on synaptic
plasticity seemed independent from GABA-mediated inhibitory
neurotransmission within the CA1 region, despite the fact
that activation of MOR was still required. In addition to the
MOR-activation coupled inhibitory neurotransmission, newer
findings have suggested that MOR activation also modulated
other MAPK signal transduction pathways, including P38 (Tan
et al., 2009), JNK (Macey et al., 2006), and ERK (Tan et al.,
2009). Therefore, the alterations of these signaling transduction
pathways following the MOR activation by fentanyl application
might play a critical role in activity-dependent synaptic plasticity.
In addition, activation of MOR in astrocytes has been reported
(Miyatake et al., 2009). In the bath application of fentanyl in
our present study, MOR activation might have also induced
MAPK signaling transduction change among astrocytes, which
could affect local environment stress and inflammation that
eventually shaped the synaptic plasticity on the excitatory
neurotransmission connections.
In addition, the bath application of fentanyl would globally
activateMOR, including the interneurons within the CA1 region.
Given that MORs are expressed in interneurons of other areas
of the hippocampus such as in the CA3 region and dentate
gyrus, the in vitro acute fentanyl exposure and washout to
hippocampal slices could also activated MOR in those regions,
which may affect Schaffer-collateral excitatory synaptic plasticity.
Although our present study did not dissect a detailed pathway, it
might provide a starting point for further investigations into the
underlying mechanism of synaptic plasticity modulation induced
by acute exposure and washout of MOR agonists.
Together our results indicate that the basic synaptic
transmission in Schaffer-collateral CA1 synapses was increased
by in vitro acute fentanyl exposure and washout, which is
secondary to MOR activation-mediated GABA disinhibition
among interneurons. However, in vitro acute fentanyl exposure
and washout also shifted synaptic plasticity in favor of synaptic
depression using a different mechanism. Understanding the
underlying mechanism of fentanyl-mediated synaptic plasticity
alterations might provide some clues for cognitive impairment
after clinical fentanyl use in patients.
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